Skip to main content

and
  1. Article

    Open Access

    A minimal physiologically based pharmacokinetic model to study the combined effect of antibody size, charge, and binding affinity to FcRn/antigen on antibody pharmacokinetics

    Protein therapeutics have revolutionized the treatment of a wide range of diseases. While they have distinct physicochemical characteristics that influence their absorption, distribution, metabolism, and excre...

    Krutika Patidar, Nikhil Pillai, Saroj Dhakal in Journal of Pharmacokinetics and Pharmacody… (2024)

  2. No Access

    Article

    Mechanistic incorporation of FcRn binding in plasma and endosomes in a whole body PBPK model for large molecules

    Monoclonal antibodies, endogenous IgG, and serum albumin bind to FcRn in the endosome for salvaging and recycling after pinocytotic uptake, which prolongs their half-life. This mechanism has been broadly recog...

    Wilhelmus E. A. de Witte, Lindsay B. Avery in Journal of Pharmacokinetics and Pharmacody… (2023)